Skip to content

Whole exome sequencing of rheumatoid arthritis

Whole-Exome Sequencing for Identification of Potential Causal Variants for Rheumatoid Arthritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17010351
Enrollment
Unknown
Registered
2017-01-07
Start date
2017-01-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

Case series:NA

Sponsors

The First People's Hospital of Changzhou
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: RA patients inclusion criteria: 1. Patient must be between 18 and 65 years of age; 2. The patient must meet 2010 American College of Rheumatology /The European League Against Rheumatism classification criteria for the diagnosis of active rheumatoid arthritis; 3. Patient has discontinued all disallowed concomitant medications foe the required time prior to the first dose of study drug; 4. Patient has signed the informed consent. Normal people inclusion criteria: 1. People must be between 18 and 65 years of age; 2. People who without auto-immune disease or arthritis syndrome; 3. People has signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Infection, pregnancy, lactating, traumatic or other stress state; 2. Severe, progressive or uncontrolled cardiac, hepatic, renal, mental disease; 3. Severe hematologic disease including leukemia, aplastic anemia, myelodysplastic syndrome and so on; 4. Use antibiotics within 1 month.

Design outcomes

Primary

MeasureTime frame
Whole exon squencing;

Countries

China

Contacts

Public ContactLiu Liang

Macau university of Science and Technology

lliu@must.edu.mo+853 66131009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026